Dr. Shiran Zimri, Vice President of R&D at NeuroSense Therapeutics, joins the Russo Edge Podcast and shares her journey as a scientist tackling neurodegenerative diseases like ALS.

In this episode, Dr. Zimri explains how NeuroSense’s innovative combination therapy, Prime C, could reshape ALS treatment by addressing multiple pathways involved in the disease. She provides a behind-the-scenes look at the company’s recent clinical trial successes and the deeply personal story that inspired the founding of NeuroSense.